Previously, we determined the crystal structures of the dimeric ligand binding region of the metabotropic glutamate receptor subtype 1. Each protomer binds Lglutamate within the crevice between the LB1 and LB2 domains. We proposed that the two different conformations of the dimer interface between the two LB1 domains define the activated and resting states of the receptor protein. In this study, the residues in the ligandbinding site and the dimer interface were mutated, and the effects were analyzed in the full-length and truncated soluble receptor forms. The variations in the ligand binding activities of the purified truncated receptors are comparable with those of the full-length form. The mutated full-length receptors were also analyzed by inositol phosphate production and Ca 2؉ response. , and Gly 293 residues, which interact with the ␥-carboxyl group of glutamate, lost their responsiveness to glutamate but not to quisqualate. Furthermore, a mutant receptor containing alanine instead of isoleucine at position 120 located within an ␣ helix constituting the dimer interface showed no intracellular response to ligand stimulation. The results demonstrate the crucial role of the dimer interface in receptor activation.
Glutamate is a major neurotransmitter in excitatory neurons in the central nervous system. Glutamate released into the synaptic space is recognized by two distinct receptors, glutamate-gated ion channels and metabotropic glutamate receptors (mGluRs) 1 (1, 2) . The mGluRs consist of eight subtypes (mGluR1 to -8), which couple with a variety of effector systems, including inositol phosphate pathway, adenylyl cyclase, ion channels, etc. The mGluRs are considered to modulate synaptic neurotransmission and thus to play roles in memory, learning, and brain disorders such as epilepsy and neurodegenerative diseases.
The mGluR consists of three regions: a large extracellular region, a seven-transmembrane-spanning region, and an intracellular region. Previously, we determined the crystal structures of the extracellular ligand-binding region (LBR) of mGluR1 (3) . In combination with biochemical studies (4, 5) , the mGluR1-LBR (m1-LBR) was found to be a homodimer consisting of two protomers. Each protomer consists of an LB1 domain and an LB2 domain. The glutamate-binding structure is a dimer composed of closed and open protomers, which differ in the relative orientation of the LB1 and LB2 domains. Without glutamate, two crystal forms of m1-LBR were obtained; one form exists as an open-open dimer, and the other is an openclosed form. The two main functioning sites were then elucidated: the ligand-recognition site and the LB1 dimer interface. In the ligand binding site, glutamate interacts mainly with 13 amino acid residues from the LB1 and LB2 domains of the protomer. We proposed that the ligand-binding domain of mGluR1 is in dynamic equilibrium between the activated state and the resting state, which are defined mainly by the different dimer interface conformations of the three crystal forms. An antagonist binding crystal structure, which was recently solved (6) , maintained the resting dimer conformation, supporting our proposal.
Recently, numerous dimer formation studies of G-proteincoupled receptors have suggested a potential level of receptor complexity and diversity (7) . However, the precise structural basis of the dimer formation has not been established. In this context, mGluR1, which is considered to be a type C G-proteincoupled receptor (8) , is unique in that its extracellular dimer interface has been defined structurally, as described above, and hence provides an opportunity to investigate the functional role of dimerization.
Here, in order to elucidate the significance and the contribution of the individual amino acid residues in ligand binding and the correlation with intracellular events, such as inositol phosphate (IP) formation and subsequent Ca 2ϩ responses, we have analyzed the functions of mutant receptors with amino acid mutations of the ligand-binding residues. Furthermore, we also mutated the residues within the helices forming the LB1 dimer interface and analyzed the effects of the mutations. One of the dimer interface mutants lost the Ca 2ϩ response to ligand stimulus, indicating the critical role of dimer interface relocation in receptor activation.
EXPERIMENTAL PROCEDURES

Materials-L-Quisqualic acid was purchased from Tocris Cookson
Ltd. (Langford Bristol, UK). L-Glutamic acid monosodium salt was purchased from Nacalai Tesque (Kyoto, Japan). LipofectAMINE 2000 and oligonucleotide primers were purchased from Invitrogen. QF/C filters were purchased from Millipore Corp. (Bedford, MA). The AG-1-X8 resin (100 -200-mesh formate form) and the Poly-Prep chromatography columns for anion exchange chromatography were obtained from Bio-Rad. All other reagents used were of molecular or analytical grade.
Construction of Expression Vectors and Oligonucleotide
Mutagenesis-The pcDNAmGluR114His plasmid, which is an expression vector for His 6 -tagged m1-LBR was made as follows. A PCR was done with the primers TO1 and HJ113 (4), using pVLmGluR113 (5) as a template. The PCR product was digested with NcoI and XbaI and was cloned into the NcoI/XbaI-digested fragment of pmGluR108 (4), resulting in pVLmGluR114His. The NotI/XbaI fragment of pVLmGluR114His was subcloned into pcDNA3.1(ϩ) (Invitrogen). pcDNAmGluR1, an expression vector for the full-length mGluR1, was made by subcloning the NotI/XbaI fragment of pmGluR102 (4) into pcDNA3.1(ϩ). For the construction of the single amino acid Y74A, R78A, S164A, S165A, S166A, S186A, T188A, L116A, I120A, L174A, L177A, and F178A mutants and the multiple amino acid mutants, the first PCR was performed with mutagenic primers (Table I) and TS35 (5Ј-TCCACTCTCGCCGGCAT-TCC-3Ј) , using pcDNAmGluR114His as the template. The second PCR was performed with the first PCR products and T7 (5Ј-TAATACGACT-CACTATAGGG-3Ј), using pcDNAmGluR114His as the template. The second PCR products were digested with NotI and Eco81I and were subcloned in place of the corresponding wild-type fragments of pcDNAmGluR114His and pcDNAmGluR1. For the construction of the D208A, Y236A, E292A, G293A, R323A, and K409A mutants, the first PCR was done with mutagenic primers and TS36 (5Ј-CCTGGCTCCGC-CTCTGTGGC-3Ј), using pmGluR114His as the template, and the second PCR was done with the first PCR products and the reverse primer (5Ј-TAGAAGGCACAGTCGAGG-3Ј). The second PCR product was digested with Eco81I and SfiI and was subcloned in place of the corresponding wild-type fragments of pcDNAmGluR114His and pcDNAmGluR1. All of the PCR products mentioned above were confirmed by sequencing.
Cell Culture and Transfection into Human Embryonic Kidney (HEK) 293 Cells-HEK 293 cells were cultured in a monolayer at 37°C, with a 5% CO 2 atmosphere in Dulbecco's modified Eagle's medium (Nissui Pharmaceutical Co., Ltd., Tokyo, Japan) lacking L-glutamine, ribonucleosides, and deoxyribonucleosides and supplemented with 2 mM GLUTAMAX TM -I (Invitrogen), 10% dialyzed fetal bovine serum (JRH Biosciences), and antibiotics (100 units/ml penicillin and 100 g/ml streptomycin). Cells were grown to 90 -95% confluence before the transient transfection. The transfections were performed using the LipofectAMINE 2000 reagent according to the manufacturer's instructions. On day 3 after transfection, cells and culture medium were harvested to examine expression and ligand binding.
Purification of the Wild-type and Mutant m1-LBRs-
The conditioned medium from m1-LBR-producing HEK 293 cells was centrifuged at 15,000 rpm for 20 min, filtered through a 0.22-m filter, and loaded on a 1-ml Ni 2ϩ -nitrilotriacetic acid-agarose column. The column was washed with 10 ml of PBS, and the bound material was eluted with PBS containing 200 mM imidazole. Aliquots of the eluate were analyzed by a ligand binding assay.
Membrane Preparation-Transfected cells (15-cm dishes) were suspended in ice-cold homogenization buffer (20 mM HEPES (pH 7.5) containing 320 mM sucrose, 1 mM phenylmethylsulfonyl fluoride, and 10 g/ml each of leupeptin, aprotinin, benzamidine, and trypsin inhibitor) and were centrifuged at 10,000 ϫ g for 10 min at 4°C. The pellet was homogenized with 20 strokes of a Potter-Elvehjem type homogenizer in 3 ml of ice-cold homogenization buffer and was centrifuged at 800 ϫ g for 5 min at 4°C. The supernatant was then centrifuged at 100,000 ϫ g for 1 h at 4°C to pellet the membranes. The membranes were divided into aliquots and were stored at Ϫ80°C until use.
Immunoblot Analysis-The proteins within the culture medium and the cell membranes were separated by SDS-PAGE and were electroblotted onto a nitrocellulose membrane (Schleicher & Schuell). The membrane was then blocked in TBST (10 mM Tris-HCl (pH 8.0), 150 mM NaCl, and 0.05% Tween 20) with 3% bovine serum albumin and was incubated for 1 h at room temperature with anti-His antibodies (Qiagen Inc., Valencia, CA), AB1551, polyclonal antibodies against a synthetic carboxyl terminus peptide of mGluR1 (Chemicon International, Inc., Temecula, CA), or the monoclonal antibody mG1Na-1 (4, 9), which was produced against the extracellular region of mGluR1. The membrane was washed and then incubated with a goat anti-mouse IgG conjugated with alkaline phosphatase. Color development was done with a commercial detection kit (Promega).
Ligand Binding Assay-For m1-LBRs, ligand binding was performed with the polyethylene glycol precipitation method, as described previously (10) . Briefly, 20 nM [ 3 H]quisqualate (999 GBq/mmol) (Amersham Biosciences) and m1-LBR samples were mixed in 150 l of binding buffer (40 mM HEPES (pH 7.5), containing 2.5 mM CaCl 2 ) at 4°C for 1 h. After the binding reaction, 6-kDa polyethylene glycol was added to the sample to a concentration of 15% with 3 mg/ml ␥-globulin. The precipitated material was washed twice with 1 ml of 8% 6-kDa polyethylene glycol and was dissolved in 1 ml of water. After the addition of 14 ml of Scintisol EX-H (Wako Pure Chemical Industries, Osaka, Japan), the radioactivity was counted in a scintillation counter. For the mGluR1s, membrane fractions of receptor-expressing HEK 293 cells were incubated with [ 3 H]quisqualate (20 nM) in a total volume of 150 l of binding buffer for 1 h at room temperature. The reaction mixture was aspirated onto GF/C filters. The filters were washed with binding buffer, briefly dried, and counted by a scintillation counter. Nonspecific binding was determined in the presence of 1 mM L-glutamate. Binding data were analyzed with the Prism 3 software (Graphpad Software, San Diego, CA). Saturation binding curves were fitted to a one-site binding model, and K d and IC 50 values were calculated. 5Ј-AGGGAACAGGCTGGTATCCA-3Ј
5Ј-TGATGAATTCGGCACTCTGTTCAGCAGCCACTGAAGA-3Ј
L174A,L177A,F178A
5Ј-CAAGTCCAGAATGCTCTCCAGGCGGCCGACATCCCACA-3Ј
Site-directed Mutagenesis in mGluR1
Determination of IP Accumulation-HEK 293 cells were grown in Dulbecco's modified Eagle's medium supplemented with 10% dialyzed fetal bovine serum, 100 units/ml penicillin, and 100 g/ml streptomycin. Cells were plated at 2 ϫ 10 5 /well of a poly-L-lysine-coated 24-well plate, and 1 g of DNA was transfected using 2 l LipofectAMINE 2000 for 4 h. After transfection, the medium was exchanged with inositol-free Dulbecco's modified Eagle's medium (ICN Biomedicals Inc., Aurora, OH) supplemented with 10% dialyzed fetal bovine serum, 100 units/ml penicillin, 100 g/ml streptomycin, and 1 Ci/ml [ 3 H]myo-inositol (95.0 Ci/mmol) (Amersham Biosciences), and the cultures were incubated at 37°C for 16 -18 h. The cells were then washed with HEPES-buffered saline (146 mM NaCl, 4.2 mM KCl, 0.5 mM MgCl 2 , 0.1% glucose, 20 mM HEPES (pH 7.4)) and were incubated for 30 min with 2 mM pyruvate and 2 units/ml glutamic-pyruvic transaminase (Sigma). After washes with HEPES-buffered saline, the cells were incubated with HEPESbuffered saline containing the agonists and 10 mM LiCl at 37°C for 1 h. The reactions were stopped by adding an equal volume of ice-cold 40 mM formic acid, and then the mixture was incubated for 30 min at 4°C. Cell extracts were loaded onto 1-ml packed volume columns of AG-1-X8 anion exchange gel resin. After loading, the columns were washed with 2 ml of 40 mM NH 4 OH (pH 9.0) and 2 ml of 40 mM ammonium formate, and the bound material was eluted with 3 ml of 2 M ammonium formate, 0.1 M formic acid. This procedure collects inositol mono-, bis-, and trisphosphates (11) . Results are expressed as the ratio of the radioactivity collected in the IP fraction over the radioactivity recovered from the solubilized cellular membranes.
Expression of mGluRs in Oocytes and Electrophysiology-The 1330-bp NotI-SfiI fragment of the mutant pcDNAmGluR1s and the 6.3-kb NotISfiI fragment of pmGR1 (12) were ligated. The resulting plasmids (mutant pmGR1s) and pmGR1 were used as templates for in vitro transcription to yield complementary RNA (cRNA). The plasmid DNA was linearized by NotI, and capped cRNA was synthesized with the MEGAscript T7 kit (Ambion, Austin, TX). Xenopus laevis oocytes were prepared, injected with 10 ng of cRNAs, and incubated for 1-2 days. Current measurements were conducted as previously described (5) .
Measurement of [Ca 2ϩ ] i -HEK 293 cells were seeded on sterile polylysine-coated coverslips (Asahi Techno Glass Corp., Tokyo, Japan) in a 12-well tissue culture plate (1.6 ϫ 10 5 /well), and were incubated overnight at 37°C. The cells were then transfected with 1.6 g of either pcDNAmGluR1 or mutant pcDNAmGluR1s and 0.4 g of pDsRed2-N1 (Clontech) with 5 l of LipofectAMINE 2000. After 24 h, the cells were loaded for 30 -60 min with Fura-2/AM (5 M) dissolved in balanced salt solution (BSS), containing 135 mM NaCl, 5.4 mM KCl, 1.8 mM CaCl 2 , 0.9 mM MgCl 2 , and 10 mM HEPES (pH 7.4), postincubated for 30 -60 min in BSS at 37°C, and maintained in BSS until the assay. About 80% of the cells in the field of view expressed mGluR1, as judged by immunocytochemistry, and almost all of them expressed DsRed2 under these conditions. No significant difference was observed in terms of the [Ca 2ϩ ] i response with and without pDsRed2 co-transfection (data not shown). Therefore, the fluorescence of DsRed2 through 499 nm was used to detect the transfectant-rich region. The coverslips were mounted in a glass flow chamber with a flow rate of 2 ml/min at 22°C. The cells were challenged with 100 M glutamate or 10 M quisqualate in BSS for 1 min and then were washed free of agonist. 100 M of carbachol in BSS was perfused for 1 min at the end of each assay in order to confirm the integrity of the IP 3 /Ca 2ϩ pathway. The chamber was mounted on a Nikon inverted stage microscope. The output from an intensified chargecoupled camera was digitized and stored by a computerized imaging system, Argus 50 (Hamamatsu Photonics, K.K., Hamamatsu, Japan). ] i . Data analysis was performed using the Prism 3.0 software.
Immunocytochemistry-HEK 293 cells seeded on sterile polylysinecoated coverslips (IWAKI) were transfected with pcDNAmGluR1 and the dimer interface mutants. After 24 h, the cells were immunoreacted with the monoclonal antibody, mG1Na-1, following the described procedures (13, 14) . Briefly, the cells were washed with PBS and directly immunoreacted with mG1Na-1 in PBS containing 5% normal goat serum for 1 h at room temperature without permeabilization. They were washed, fixed with 4% paraformaldehyde in PBS for 5-10 min at room temperature, and permeabilized with 0.1% Triton X-100 in PBS containing 5% normal goat serum for 1 h. They were immunoreacted with the secondary antibody, fluorescein anti-mouse IgG (H ϩ L) (Vector Laboratories, Burlingame, CA) and were visualized using a Carl Zeiss confocal microscope, model LSM510.
RESULTS
We constructed mutant receptors containing point mutations in the ligand binding residues, as determined by our crystallographic study (Fig. 1) . We have designed two types of receptors: one type is the soluble form of the receptor, including the N terminus to Glu 522 , just before the start residue of the cysteinerich sequence ahead of the membrane-spanning domain, and the other is the full-length membrane-bound form of the receptor. Fig. 2A shows the immunoblot analysis of the mutant proteins expressed in the culture medium of the HEK 293 cells transfected with plasmids encoding the mutant soluble form of the receptors. The mutants sS164A, sS186A, sG293A, and sK409A (where the small letter "s" represents the soluble form) were expressed at levels similar to that of the nonmutated soluble form of mGluR1 (sWT) (formerly designated as mGluR114 (5) with a His tag). The sY74A, sS165A, sE292A, sD318A, and sR323A mutants were expressed at lower levels. The sR78A, sT188A, sD208A, and sY236A mutants were not detected in the culture medium. Although Ser 166 does not interact with the ligand in the crystal, the sS166A mutant was made as a control and was expressed well. These soluble forms of the receptors secreted into the culture medium were partially purified on nickel resin, and their ligand-binding capacities were examined, as shown in Fig. 2B . The partially purified soluble form receptor proteins, sS164A, sS186A, sR323A, and sK409A, exhibited significant [ 3 H]quisqualate binding, as shown in Fig. 2B . The sY74A and sG293A mutants lost their binding capacities. Since sufficient amounts of purified protein were not obtained from the mutants sR78A, sS165A, sT188A, sD208A, sY236A, sE292A, and sD318A, the binding capacities of these mutants were not estimated. The IC 50 values of glutamate for the sS164A and sS186A mutants were comparable with that of the wild type soluble form receptor, as shown in Fig. 2C and Table II . On the other hand, the sR323A and sK409A mutants showed 1-order of magnitude higher values.
Next, the mutant full-length receptors, which possess an amino acid point mutation, were constructed, and their expression and ligand binding capacities were examined. An immunoblot analysis of membrane preparations derived from the cells transfected with plasmids encoding the mutant receptors and the wild type mGluR1 (WT) is shown in Fig. 3A . Although the R78A, T188A, and Y236A mutants were not detected in their soluble forms, their full-length form mutants were detected in the immunoblot. The D208A mutant was hardly detected. Although the ligand binding values obtained with the membrane preparations in Fig. 3B were 2-3 orders of magnitude less than those of the soluble forms in the medium (Fig.  2B ) (see pmol versus fmol in the units at the ordinate), the variations in the expression levels among the mutants seem to parallel those of the soluble forms of the mutants. Again, the S164A, S186A, R323A, and K409A mutants showed significant binding values. Furthermore, the glutamate IC 50 values for these mutants are strikingly comparable with those for the soluble form mutants, as shown in Fig. 3C and Table II . These data are compatible and support our previous experiment involving the functional extraction of the ligand binding region without the membrane region (4).
In order to examine the effects of the amino acid mutations in the ligand binding core on intracellular signaling, the enhancement of the IP concentration evoked by glutamate and quisqualate stimuli was investigated in HEK 293 cells (Fig. 4) . 1 mM glutamate stimulation of the cells expressing the S164A, S186A, R323A, and K409A mutants evoked IP responses comparable with that of the wild type mGluR1. The responses to the quisqualate stimulation were almost parallel to those of the glutamate stimulation. The S165A and E292A mutants showed an intermediate level response with glutamate. Although a lower glutamate response level was observed with the Y236A mutant, the response with quisqualate was almost lost. Interestingly, in the Y74A and R78A mutants, the response to glutamate was undetectable; however, a significant response to quisqualate was observed. The amplitude of the quisqualate response in the G293A mutant was very small but appears to be significant. No response to either ligand was detected with the T188A, D208A, and D318A mutants, which hardly expressed the soluble form and exhibited weak ligand binding capacities in the full-length forms. In the wild type mGluR1, the IP level before ligand dose-response curves in inhibiting stimulation (white bar) was significantly higher than that in the cells transfected with the vector plasmid alone (mock).
Since the so-called basal level of IP production by unliganded mGluR1 expression, also observed in Ref. 15 , was lost in the mutants S165A and E292A, which showed reduced ligand coupling, it seemed that the "basal level" required agonistlike conformational changes. In these mutants, movement of the LB1-LB2 interdomain orientation angle might be restricted at the basal state, and thus the dimer interface relocation, possibly related to closing of at least one protomer, might be hampered. Alterations of the intracellular Ca 2ϩ concentrations, which are a downstream effect of IP production, were examined, as shown in Fig. 5A . Glutamate elicited an enhancement of the intracellular Ca 2ϩ concentration in cells expressing the S164A, S165A, S186A, E292A, R323A, and K409A mutants as well as the mGluR1 (WT) and the control mutant, S166A. These data are comparable with the increment of the IP concentration in these mutants. Thus, the intermediate level of IP enhancement in the S165A and E292A mutants seems to be significant. These data indicate the different sensitivities between the ligand binding assay and the intracellular Ca 2ϩ measurement. The T188A, D208A, Y236A, and D318A mutants did not show any Ca 2ϩ response. In the Y74A, R78A, and G293A mutants, only quisqualate showed a Ca 2ϩ response. The Ca 2ϩ responses in the Y74A and R78A mutants seemed to be comparable with their IP responses.
We also examined the membrane currents in oocyte expression systems, as shown in Fig. 5B . After the injection of cRNAs corresponding to the mGluR1 and its mutants, ligands were applied to the oocytes, and their membrane potentials were measured. The characteristic variation in the amplitude response was somewhat similar to that in the intracellular Ca 2ϩ response. The minor differences were that both ligands elicited membrane currents in Y236A, and quisqualate caused a small response in D318A.
In our previous structural studies, the LB1 dimer interface, which mainly consists of helices B and C, is crucial for setting and selecting the activation state in the ligand binding region. Therefore, we mutated the five main amino acid residues in the interface and analyzed their properties. (Fig. 6A) . The expression levels of these dimer interface mutants appeared to be lower than that of the wild type receptor, suggesting some difficulty in the protein folding or stability. The ligand binding capacities of these mutants, except for I120A, were not clearly detected, probably due to the low expression levels and the low binding assay sensitivity (Fig. 6B) . Next, functional assays were performed, as shown in Figs. 7, A and B. The L116A, L174A, L177A, and F178A mutants showed IP enhancement at magnitudes comparable with that of the wild type control. In contrast, the IP response in the I120A mutant was obscure. Notably, the Ca 2ϩ response was completely lost in the I120A mutant (Fig. 7B) . The membrane currents induced by the increased intracellular Ca 2ϩ concentration were measured by an oocyte expression system. Again, the I120A mutant showed no membrane current change, despite the maintenance of the current change in other mutants (data not shown). The cell surface expression of these dimer interface mutants was probed immunocytochemically, as shown in Fig. 8 . The mG1Na-1 monoclonal antibody detected the mutants, including I120A, as well as the wild type mGluR1 under the nonpermeabilized condition. Thus, the I120A mutant appears to lose the signaling function, despite the maintenance of its ligand binding capability. We obtained an ϳ350 nM K d value of [ 3 H]quisqualate for the I120A mutant, which ruled out the possibility that the elimination of the signaling capacity in the I120A mutant was due to a loss of ligand affinity. 
DISCUSSION
Based on the crystal structure of the ligand-binding region of mGluR1, we performed an amino acid mutagenesis of two groups of amino acid residues, one series of residues interacting with the ligand, glutamate, and the other series of residues residing in the dimer interface. We prepared mutants of the full-length receptor and the truncated receptor containing only the ligand-binding region. The relationship between ligandbinding and intracellular signaling in the mutant receptors was extensively examined along with the wild type receptor.
Among the 14 full-length mutants, the S164A, S186A, R323A, and K409A mutants were expressed well and showed ligand binding capacities comparable with that of the wild type. These mutants elicited normal IP responses and intracellular calcium increments. The S165A and E292A mutants did not show remarkable binding, but their intracellular responses to both ligands were clear, indicating that the intracellular signaling assay is more sensitive than the present ligand binding assay. Interestingly, the Y74A, R78A, and G293A mutants lost their responses to glutamate but maintained their responsiveness to quisqualate. Jensen et al. (16) reported that the potency of glutamate is much lower than that of quisqualate when Arg 78 is mutated to leucine. The T188A, D208A, Y236A, and D318A mutants lost their responses to both ligands. The side chains of these four residues, which are conserved among all mGluR subtypes, interact with the ␣-amino group of glutamate. The manner of the ␣-amino group interaction with the hydroxyl group of Thr 188 and the carboxylate of Asp 318 is a hydrogen bond, whereas the interactions with Asp 208 and Tyr 236 are a salt bridge and a cation-interaction, respectively. The 4-fold increase of the K d value of quisqualate in the S186A mutant (Table II) may be caused by an abrogation of the interaction between the backbone carbonyl oxygen of Ser 186 with the amino group. As the expressions of the T188A, D208A, and Y236A mutants in the soluble form were unsuccessful, these residues may also be important for the folding of the receptor protein. Intriguingly, water molecules are not involved in the recognition of the ␣-amino group, implying the importance of the side chain orientations of the four residues. This is in contrast to the adaptable recognition of the ␥-carboxyl group through the water molecules. The binding mode and the environment of the agonists, including glutamate, in the binding core of the AMPA receptor (17) suggest that the interactions with the ␣-amino group are conserved among the several agonists, although the interactions with the ␣-carboxyl group differ between the mGluR1 and AMPA receptors. Thus, the socalled glutamate binding fold may have evolved with the preservation of the binding property to the amino group of the ligand.
We used labeled quisqualate as a ligand in our binding assay. The displacement experiment of labeled binding quisqualate by an excess of unlabeled glutamate not quisqualate was performed to assess the specific binding. Quisqualate differs from glutamate by the presence of 3,5-dioxo-1,2,4-oxadiazolidine, as shown in Fig. 1A 3 H]IPs accumulated over total radioactivity in the membrane fraction and represent the means Ϯ S.E. of at least three independent experiments performed in duplicate or triplicate. B, cells were transfected with pcDNAmGluR1 and mutant receptors. Glutamate (100 M in BSS) was used for a 1-min challenge. The peak and basal concentrations of intracellular Ca 2ϩ were determined, as described under "Ex- with these residues may be different, due to the presence of the ring. Quisqualate may utilize distinct binding residues, which may cause its higher affinity as compared with that of glutamate. This may reflect the loss of glutamate signaling and the preservation of quisqualate signaling in the mutants Y74A, R78A, and G293A. (19) . Those data are consistent with the present data. In addition, alanine mutations of Ser 159 in mGluR4 and Ser 145 in mGluR2, which correspond to Ser 165 in mGluR1, abolished the ligand binding and functional responses. The S165A mutation did not completely eliminate the glutamate-and quisqualate-induced signaling in the present study, which is consistent with the report of O'Hara et al. (20) that the mutant retained the functional activity, despite its reduced affinity. Thus, Ser 165 in mGluR1 does not appear to be as critical for functional expression as the four residues mentioned above. However, notably, the basal activity measured by the intracellular IP level was lost in the S165A mutant. The inefficient expression of this mutant in the truncated version, in addition to the reported key roles of the corresponding residues in related receptors such as the calcium-sensing receptor (21) and GABA-B receptor (22) , suggests us that the residue is important for the ligand binding domain fold. Since the main chain nitrogen of Ser 165 is hydrogen-bonded with the ␣-carboxyl oxygen of glutamate, a similar main chain interaction may remain after the alanine replacement. Thus, the corresponding residues in the other subtypes may interact with glutamate in somewhat different manners.
In previous structural studies, we showed that mGluR1 is a homodimer containing the dimer interface, which consists of the B and C helices in each of the two LB1 domains. The construction of the dimer interface defines the two states of the ligand binding domain, the activated state and the resting state, which are supposed to be in dynamic equilibrium. The recent structural analysis of the antagonist binding crystal reinforces our proposal. Thus, to clarify the significance of the LB1 interface in the signaling into the intracellular environment, the dimer interface was analyzed. The ligand binding capacities of these mutants were markedly decreased as compared with that of the wild type. Out of the five single amino acid mutants in the hydrophobic interface, four point mutants responded to the glutamate stimulus; however, I120A lost the intracellular responses. Namely, the increments of both the IP concentration and the intracellular Ca 2ϩ were abolished. Although our ligand binding assay is not as sensitive as the signaling assay, the four other point mutants showed clear intracellular responses, despite their lower levels of ligand binding than that of I120A mutant. Notably, the rotation axis of the dimer interface passes in the close vicinity of Ile 120 . The alanine replacement of Ile 120 may hinder the ability of the dimer interface to set the activated state, even upon ligand binding, although the small reduction of the ligand affinity might contribute to the signal loss to some extent. The structural determination of this mutant is intriguing. These results demonstrate that the LB1 interface performs the critical role of a gateway for determining the initial activation status of the receptor molecule and also provides an indispensable structural backbone for the dimer formation. Thus, the dimer interface may provide a new target for the modification of signal transmission in mGluRs. The dominant-negative character of the mutant is under investigation.
In conclusion, we performed a systematic site-directed mutagenesis study of mGluR1, focusing on the ligand binding site and the dimer interface, which were revealed by the crystal structure. The mutant analyses of the ligand binding site disclosed the critical residues that directly bind to the ␣-amino group of glutamate. The alanine replacement of isoleucine 120, located close to the relocation axis of the dimer interface, abolished the Ca 2ϩ response, indicating the crucial role of the dimer interface relocation for the initial activation of mGluR1.
